IndiaOne Finance - Company Dashboard

Governance Classic Home

Alembic Pharmaceuticals LtdPharmaceuticalsINE901L01018Consolidated₹845.75+19.75 (+2.39%)Jun-26

Valuation

Market Cap₹16.62K Cr

TTM PE23.98x

Forward PE24.52x

PEG8.66

Book Value₹288.70

P/B2.93x

TTM EPS₹35.27

Fwd EPS₹34.49

TTM Revenue₹7.78K Cr

TTM PAT₹689.56 Cr

TTM EBITDA₹1.17K Cr

TTM EBIT₹826.49 Cr

Last Qtr PAT₹172.36 Cr

Last Qtr EBITDA₹331.86 Cr

Last Qtr EBIT₹234.15 Cr

Profitability

ROE12.15%

ROCE11.57%

TTM NPM8.86%

TTM EBITDA %15.02%

Curr OPM7.96%

Last OPM10.76%

Curr NPM—

Last NPM—

Curr EPS₹8.80

Last EPS₹10.31

Balance sheet

Equity₹39.31 Cr

Reserve₹5.64K Cr

Total Debt₹1,429.94 Cr

D/E0.25x

Interest %16.02%

Curr Interest₹27.61 Cr

Price / range

Close₹845.75

vs 52W High—

vs 52W Low—

MA50—

MA200—

Returns

1D+2.39%

1W+4.29%

1M+2.57%

3M+12.81%

6M+25.16%

1Y-11.76%

2Y-28.85%

3Y+7.99%

5Y+8.67%

Diwali+0.89%

Sector peers — Pharmaceuticals

Company	Close	Mkt Cap	TTM P/E	ROE
SUNPHARMA	1837.30	₹4.41L Cr	36.45	14.50%
DIVISLAB	9375.00	₹2.49L Cr	85.06	17.45%
TORNTPHARM	4840.00	₹1.84L Cr	77.32	25.70%
ZYDUSLIFE	1160.00	₹1.16L Cr	25.85	16.94%
CIPLA	1394.50	₹1.13L Cr	33.41	9.75%
LAURUSLABS	1954.00	₹1.06L Cr	96.45	20.58%
AUROPHARMA	1734.00	₹99.77K Cr	27.09	9.79%
DRREDDY	1185.00	₹98.91K Cr	30.63	8.40%

Financial Results

Quarterly and yearly P&L · YoY % on Revenue, Total Income, Expenditure, EBITDA, EBIT, PBT, Net Profit and EPS

Metric	Jun-26	Mar-26	Dec-25	Sep-25	Jun-25	FY25-26
Revenue	1,868.06+25.0%	1,718.74	1,642.24	1,796.24	1,494.17	6,651.38
Other Income	14.04	25.88	10.73	11.49	7.79	55.90
Total Income	1,882.10+25.3%	1,744.62	1,652.97	1,807.73	1,501.96	6,707.28
Interest	21.41	19.42	21.65	22.81	22.64	86.51
Expenditure	-1,626.20-18.1%	-1,546.40	-1,471.96	-1,591.38	-1,376.44	-5,986.18
PBDT	0	0	0	0	0	0
EBITDA	345.81+61.8%	274.07	271.60	303.31	213.74	1,062.71
Depreciation	-82.54	-82.31	-79.67	-75.64	-73.37	-311
EBIT	263.27+87.6%	191.76	191.93	227.67	140.37	751.71
PBT	255.90+103.9%	173.46	138.78	216.35	125.52	654.11
Tax	-58.94	69.61	-24.31	-36.99	-22	-13.69
Equity	39.31	39.31	39.31	0	39.31	39.31
OPM	13.60	9.94	8.40	12.04	8.36	9.75
Net Profit	196.96+90.3%	243.07	114.47	179.36	103.52	640.42
NPM	10.46	13.93	6.93	9.99	6.89	9.55
EPS	10.02+90.1%	12.37	5.82	9.12	5.27	32.58

Yearly results

Last 6 financial years · YoY % vs previous FY

Metric	FY 25-26	FY 24-25	FY 23-24	FY 22-23	FY 21-22	FY 20-21
Revenue	6,651.38+10.3%	6,032.63+2.7%	5,874.06+14.1%	5,149+3.0%	4,996.61-1.1%	5,051.44
Other Income	55.90	47.88	31.32	3.55	49.98	9.73
Total Income	6,707.28+10.3%	6,080.51+3.0%	5,905.38+14.6%	5,152.54+2.1%	5,046.58-0.3%	5,061.17
Expenditure	-5,986.18-9.1%	-5,484.79-5.5%	-5,201.15-8.2%	-4,806.61-16.2%	-4,138.13-13.5%	-3,644.58
Interest	-86.51	-76.47	-54.47	-49	-16.67	-12.77
PBDT	0	0	0	0	0	0
EBITDA	1,062.71+17.9%	901.39-9.7%	998.52+50.3%	664.34-37.0%	1,054.46-32.9%	1,572.23
Depreciation	-311	-277.08	-271.14	-272.95	-179.31	-152.60
EBIT	751.71+20.4%	624.31-14.2%	727.38+85.8%	391.39-55.3%	875.15-38.4%	1,419.63
PBT	654.11+7.5%	608.59-13.6%	704.23+103.6%	345.93-61.9%	908.45-35.9%	1,416.59
Tax	-13.69	-105.47	-37.75	0.80	-114.45	-241.20
Equity	39.31	39.31	0	0	0	0
OPM (%)	9.75	10.01	12.00	7.00	18.00	28.00
Net Profit	640.42+27.3%	503.12-24.5%	666.48+92.2%	346.73-56.3%	794-32.4%	1,175.39
NPM (%)	9.55	8.27	11.00	7.00	16.00	23.00
EPS (Rs)	32.58+27.3%	25.60-24.5%	33.91+92.2%	17.64-56.3%	40.39-33.4%	60.67
CEPS	32.58	25.60	33.91	17.64	40.39	60.67

Metric	Jun-26	Mar-26	Dec-25	Sep-25	Jun-25	FY25-26
Revenue	2,149.77+25.7%	1,847.72	1,876.31	1,910.15	1,710.72	7,344.90
Other Income	14.93	25.50	15.50	6.91	6.50	54.41
Total Income	2,164.70+26.1%	1,873.22	1,891.81	1,917.06	1,717.22	7,399.31
Interest	27.61	22.56	23.31	24.23	23.52	93.63
Expenditure	-1,943.23-27.3%	-1,730.94	-1,686.24	-1,694.76	-1,526.67	-6,638.62
PBDT	0	0	0	0	0	0
EBITDA	331.86+18.0%	227.92	293.50	315.69	281.34	1,118.46
Depreciation	-97.71	-88.58	-80.12	-76.07	-73.77	-318.55
EBIT	234.15+12.8%	139.34	213.38	239.62	207.57	799.91
PBT	221.47+16.2%	117.52	163.34	222.30	190.55	693.71
Tax	-49.50	82.91	-29.55	-40	-36.47	-23.12
Equity	39.31	39.31	0	0	39.31	39.31
OPM	10.23	6.27	8.63	11.60	11.10	9.38
Net Profit	172.36+12.2%	201.54	131.95	183.71	153.63	670.83
NPM	7.96	10.76	6.97	9.58	8.95	9.07
EPS	8.80+12.1%	10.31	6.76	9.40	7.85	34.33

Yearly results

Last 6 financial years · YoY % vs previous FY

Metric	FY 25-26	FY 24-25	FY 23-24	FY 22-23	FY 21-22	FY 20-21
Revenue	7,344.90+10.1%	6,672.08+7.1%	6,228.63+10.2%	5,652.62+6.5%	5,305.79-1.6%	5,393.13
Other Income	54.41	42.55	28.31	2.74	50.46	10.02
Total Income	7,399.31+10.2%	6,714.63+7.3%	6,256.93+10.6%	5,655.36+5.6%	5,356.25-0.9%	5,403.15
Expenditure	-6,638.62-10.3%	-6,021.20-7.1%	-5,624.13-6.7%	-5,269.86-11.3%	-4,736.14-17.4%	-4,035.06
Interest	-93.63	-78.77	-56.19	-50.17	-17.73	-16.02
PBDT	0	0	0	0	0	0
EBITDA	1,118.46+10.9%	1,008.23+8.0%	933.36+31.8%	708.36-19.0%	874.16-43.9%	1,557.56
Depreciation	-318.55	-278.58	-272.67	-275.43	-286.78	-183.47
EBIT	799.91+9.6%	729.65+10.4%	660.69+52.6%	432.93-26.3%	587.38-57.3%	1,374.09
PBT	693.71-1.8%	706.30+11.6%	632.81+64.1%	385.51-37.8%	620.11-54.7%	1,368.09
Tax	-23.12	-125.16	-16.01	-12.60	-104.46	-253.31
Equity	39.31	39.31	0	0	0	0
OPM (%)	9.38	10.52	10.11	6.82	11.58	25.32
Net Profit	670.83+15.3%	582.01-5.5%	615.82+80.1%	341.99-34.4%	520.94-54.6%	1,146.52
NPM (%)	9.07	8.67	9.84	6.05	9.73	21.22
EPS (Rs)	34.33+15.7%	29.68-5.3%	31.33+80.1%	17.40-37.3%	27.76-54.3%	60.81
CEPS	34.33	29.68	31.33	17.40	27.76	60.81

Corporate Actions

Dividends, bonus issues, and stock splits

Dividend

Year	Type	Amount	Ex-Date
2026	Final Dividend	12	29 Jul 2026
2025	Final Dividend	11	29 Jul 2025
2024	Final Dividend	11	15 Jul 2024
2023	Final Dividend	8	28 Jul 2023
2023	Interim Dividend	10	17 Aug 2022
2021	Final Dividend	14	19 Jul 2021
2020	Interim Dividend	7	16 Mar 2020
2020	Special Dividend	3	16 Mar 2020
2019	Final Dividend	5.5	18 Jul 2019
2018	Final Dividend	4	18 Jul 2018
2017	Final Dividend	4	11 Jul 2017
2016	Final Dividend	4	20 Jul 2016
2015	Final Dividend	3.5	22 Jul 2015
2014	Final Dividend	3	17 Jul 2014
2013	Final Dividend	2.5	29 Jul 2013
2012	Final Dividend	1.4	31 Jul 2012

Bonus

No bonus history.

Split

No split history.

Financial Results

Standalone

Yearly results

Yearly

Consolidated

Yearly results

Yearly

Corporate Actions

Dividend

Bonus

Split